Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.036 | 0.9 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |